A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Washington, D.C. – U.S. Senator Marco Rubio (R-FL) joined a bipartisan group of senators in urging U.S. Secretary of Defense James Mattis to consider a pilot program to improve access and reduce the costs of prescription drugs in the TRICARE program, which serves active duty military personnel, National Guard, reservists, retired servicemembers and their families.
“We believe the TRICARE Acquisition Cost Parity Pilot Program for Retail Pharmacy is a sensible approach to reducing prescription drug costs in the TRICARE program,” states the senators’ letter. “Because the FY2017 NDAA requires the pilot to begin on October 1, 2017, we urge you to act quickly to consider the pilot program. In addition to reducing costs to the TRICARE program, this pilot will help small businesses contribute back to their local economies and will help to sustain the pharmacy benefit upon which our deserving military veterans and families rely.”
Senators Tom Cotton (R-AR), Gary Peters (D-MI), James Inhofe (R-OK), Johnny Isakson (R-GA), Thom Tillis (R-NC), Bill Cassidy, M.D. (R-LA), Jerry Moran (R-KS), Pat Roberts (R-KS), John Kennedy (R-LA), Michael Rounds (R-SD), John Cornyn (R-TX), Debbie Stabenow (D-MI), Shelley Moore Capito (R-WV), Luther Strange (R-AL), Heidi Heitkamp (D-ND), Jon Tester (D-MT), Dean Heller (R-NV), Rob Portman (R-OH), Bob Menendez (D-NJ), and Bob Casey (D-PA) also signed the letter.
Currently, all TRICARE beneficiaries must get non-generic medications from a military treatment facility (MTF) or through mail order, but have no option to visit a pharmacy in person. The pilot program, which was established in the National Defense Authorization Act (NDAA) for Fiscal Year 2017, will allow beneficiaries to get their medications from local pharmacies while preserving access through the existing MTF and mail order systems, and reduce costs by allowing the Department of Defense to purchase non-generic medications at the same lower rate it pays for drugs dispensed through the mail or MTFs. The pilot will also provide additional options for the families of retired servicemembers, National Guard members and reservists who may not live near an MTF to visit a pharmacy in person to purchase their medications.
The full text of the letter is below:
The Honorable James Mattis
Secretary of Defense
Department of Defense
1000 Defense Pentagon
Washington, DC 20301
Dear Secretary Mattis:
The undersigned members of the Senate urge the timely consideration of a pilot provision of the FY2017 National Defense Authorization Act (NDAA) that will reduce prescription drug costs for the Department, protect beneficiary health, and improve choice in points of access for beneficiaries.
We believe the TRICARE Acquisition Cost Parity Pilot Program for Retail Pharmacy is a sensible approach to reducing prescription drug costs in the TRICARE program. Currently, all TRICARE beneficiaries are required to obtain their non-generic maintenance medications at a military treatment facility (MTF) or through mail order. This pilot will restore access to chain and small business pharmacies for retired beneficiaries who rely on non-generic maintenance medications, maintain access to existing mail order and MTF options and reduce costs.
Cost savings would be achieved through the elimination of the acquisition cost disparity among pharmacy service locations by giving the DoD the authority to require that brand medications dispensed in the retail setting be purchased at the much lower rate it currently pays for the same medications dispensed in mail or MTFs. This change will save the DoD money through both lower purchasing costs and reduced administrative costs.
Because the FY2017 NDAA requires the pilot to begin on October 1, 2017, we urge you to act quickly to consider the pilot program. In addition to reducing costs to the TRICARE program, this pilot will help small businesses contribute back to their local economies and will help to sustain the pharmacy benefit upon which our deserving military veterans and families rely.
We look forward to working with the DoD on this program.